Evidence map›Paper›PMID 31661019›Full record

ArticleClinical epigenetics2019

Selective demethylation of two CpG sites causes postnatal activation of the Dao gene and consequent removal of D-serine within the mouse cerebellum.

Mariella Cuomo, Simona Keller, Daniela Punzo, Tommaso Nuzzo, Ornella Affinito, Lorena Coretti, Massimo Carella, Valeria de Rosa, Ermanno Florio, Francesca Boscia and 5 more

Open access · goldAbstract read
In one paragraph

Article in Clinical epigenetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Impact of Social Defeat Stress on DNA Methylation in Drd2, Nr3c1, and Stmn1 in Wild-type and Stmn1 Knock-out Mice.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2022
    Article
  7. Evaluation ofOncology research · 2022
    Article
  8. Review
  9. DNA methylation impact on Fabry disease.Clinical epigenetics · 2021
    Review
  10. DNA Methylation Profiles ofBiomolecules · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Mariella CuomoDepartment of Molecular Medicine and Medical Biotecnology, Universita' degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131, Naples, Italy.
Simona KellerDepartment of Molecular Medicine and Medical Biotecnology, Universita' degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131, Naples, Italy.
Daniela PunzoCeinge Biotecnologie Avanzate, via Gaetano Salvatore 482, 80145, Naples, Italy.
Tommaso NuzzoTranslational Neuroscience Unit, IRCCS Casa Sollievo della Sofferenza, Viale Cappuccini, 71013, San Giovanni Rotondo, Italy.
Ornella AffinitoDepartment of Molecular Medicine and Medical Biotecnology, Universita' degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131, Naples, Italy.
Lorena CorettiDepartment of Molecular Medicine and Medical Biotecnology, Universita' degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131, Naples, Italy.
Massimo CarellaTranslational Neuroscience Unit, IRCCS Casa Sollievo della Sofferenza, Viale Cappuccini, 71013, San Giovanni Rotondo, Italy.
Valeria de RosaDepartment of Neuroscience, Reproductive and Dentistry Sciences, Università degli Studi di Napoli 'Federico II', via S. Pansini 5, 80131, Naples, Italy.
Ermanno FlorioDepartment of Molecular Medicine and Medical Biotecnology, Universita' degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131, Naples, Italy.
Francesca BosciaDepartment of Neuroscience, Reproductive and Dentistry Sciences, Università degli Studi di Napoli 'Federico II', via S. Pansini 5, 80131, Naples, Italy.
Vittorio Enrico AvvedimentoDepartment of Molecular Medicine and Medical Biotecnology, Universita' degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131, Naples, Italy.
Sergio CocozzaDepartment of Molecular Medicine and Medical Biotecnology, Universita' degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131, Naples, Italy.
Francesco ErricoDepartment of Agricultural Sciences, University of Naples "Federico II", via Università 100, 80055, Portici, Italy.
Alessandro UsielloCeinge Biotecnologie Avanzate, via Gaetano Salvatore 482, 80145, Naples, Italy. usiello@ceinge.unina.it.
Lorenzo ChiariottiDepartment of Molecular Medicine and Medical Biotecnology, Universita' degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131, Naples, Italy. chiariot@unina.it.
University of Naples Federico II · ITInstitute for Experimental Endocrinology and Oncology · ITCeinge Biotecnologie Avanzate (Italy) · ITCasa Sollievo della Sofferenza · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProgrammed epigenetic modifications occurring at early postnatal brain developmental stages may have a long-lasting impact on brain function and complex behavior throughout life. Notably, it is now emerging that several genes that undergo perinatal changes in DNA methylation are associated with neuropsychiatric disorders. In this context, we envisaged that epigenetic modifications during the perinatal period may potentially drive essential changes in the genes regulating brain levels of critical neuromodulators such as D-serine and D-aspartate. Dysfunction of this fine regulation may contribute to the genesis of schizophrenia or other mental disorders, in which altered levels of D-amino acids are found. We recently demonstrated that Ddo, the D-aspartate degradation gene, is actively demethylated to ultimately reduce D-aspartate levels. However, the role of epigenetics as a mechanism driving the regulation of appropriate D-ser levels during brain development has been poorly investigated to date.

methodsWe performed comprehensive ultradeep DNA methylation and hydroxymethylation profiling along with mRNA expression and HPLC-based D-amino acids level analyses of genes controlling the mammalian brain levels of D-serine and D-aspartate. DNA methylation changes occurring in specific cerebellar cell types were also investigated. We conducted high coverage targeted bisulfite sequencing by next-generation sequencing and single-molecule bioinformatic analysis.

resultsWe report consistent spatiotemporal modifications occurring at the Dao gene during neonatal development in a specific brain region (the cerebellum) and within specific cell types (astrocytes) for the first time. Dynamic demethylation at two specific CpG sites located just downstream of the transcription start site was sufficient to strongly activate the Dao gene, ultimately promoting the complete physiological degradation of cerebellar D-serine a few days after mouse birth. High amount of 5'-hydroxymethylcytosine, exclusively detected at relevant CpG sites, strongly evoked the occurrence of an active demethylation process.

conclusionThe present investigation demonstrates that robust and selective demethylation of two CpG sites is associated with postnatal activation of the Dao gene and consequent removal of D-serine within the mouse cerebellum. A single-molecule methylation approach applied at the Dao locus promises to identify different cell-type compositions and functions in different brain areas and developmental stages.

Indexed as

DNA MethylationTranscriptional Activation5-MethylcytosineAnimalsAnimals, NewbornCerebellumCpG IslandsD-Amino-Acid OxidaseD-Aspartic AcidEpigenesis, GeneticGene Expression Regulation, DevelopmentalHigh-Throughput Nucleotide SequencingMaleMiceSequence Analysis, DNASerine5-hydroxymethylcytosine5-MethylcytosineD-Amino-Acid OxidaseDao1 protein, mouseD-Aspartic AcidSerine5-HydroxymethylcytosineBrain DNA methylationD-amino acidsDNA methylation in psychiatric disordersNeuroepigenetics

Identifiers

PMID31661019
PMCPMC6819446
OpenAlexW2982471114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.